A theme covering fluctuations in revenue and operating profit in the pharmaceutical and fine chemicals businesses, driven by order intake and product trends in each segment. It covers performance fluctuations within both businesses, including strong performance by the pharmaceutical ingredients platform and declining revenue and profit in the fine chemicals business due to limited CMC orders and fewer large-scale CDMO products.